Patent Opposition Database

Lysine Specific Demethylase (LSD1)

Type: Drug Disease: Cancer Countries: Argentina Related documents: 1

Pneumococcal Conjugate Vaccine (PCV)

Type: Drug Disease: Pneumonia Countries: India and Korea (Republic of) Related documents: 21

Abacavir (ABC)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Abacavir/Lamivudine (ABC/3TC)

Type: Drug Disease: HIV/AIDS Countries: Europe (EPO) Related documents: 1

Amino acid dietary supplement (Not Applicable)

Type: Drug Disease: cancer Countries: Argentina Related documents: 1

Amlodipine/Losartan/Rosuvastatin (ALR)

Type: Drug Disease: Hyperlipidaemic, Hypertension Countries: Argentina Related documents: 1

Amprenavir (AMP)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 5

Atazanavir (ATV)

Type: Drug Disease: HIV/AIDS Countries: Brazil and India Related documents: 14

Atorvastatin (Atorvastatin)

Type: Drug Disease: Cholesterol Countries: Dominican Republic Related documents: 2

Bedaquiline (BDQ)

Type: Drug Disease: Tuberculosis Countries: Brazil, Europe (EPO), India, Thailand, and Ukraine Related documents: 24

Bedaquiline, Pretomanid and Linezolid (BPaL)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 3

Bempedoic acid (Not Applicable)

Type: Drug Disease: Hypercholesterolemia Countries: Argentina Related documents: 1

Benzylguanidine (BG)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 1

Beta Secretase Inhibitor ( BACE Inhibitor)

Type: Drug Disease: Alzheimer's Countries: Argentina Related documents: 1

Botulinum Toxin (BTX-A)

Type: Drug Disease: Erectile dysfunction Countries: Argentina Related documents: 1

Brigatinib (BGB)

Type: Drug Disease: non-small cell lung cancer (NSCLC Countries: Argentina Related documents: 1

Buprenorphine (Bup/nx)

Type: Drug Disease: Opioid dependence and addiction Countries: Argentina Related documents: 1

CRISPR/Cas9 (CRISPR/Cas9)

Type: Drug Disease: Various Countries: Colombia Related documents: 1

Cabotegravir (.CAB)

Type: Drug Disease: HIV Countries: India Related documents: 4

Cannabidiol (CBD)

Type: Drug Disease: Epilepsy Countries: Argentina Related documents: 2

Cariprazine (Not Applicable)

Type: Drug Disease: schizophrenia, bipolar disorder Countries: Argentina Related documents: 1

Carvedilol+Hydrochlorothiazide (CAR + HCTZ)

Type: Drug Disease: Heart disease Countries: Argentina Related documents: 1

Celecoxib (CLX)

Type: Drug Disease: Osteoarthritis Countries: Argentina Related documents: 1

Cetirizine (CTZ)

Type: Drug Disease: Asthma Countries: Argentina Related documents: 1

Clodronic acid (Not Applicable)

Type: Drug Disease: Osteoarthritis Countries: Argentina Related documents: 1

Cyclobenzaprine (C)

Type: Drug Disease: Sleeping disorder Countries: Argentina Related documents: 2

DPP-4 inhibitors (DPP-4 )

Type: Drug Disease: Diabetes Countries: Dominican Republic Related documents: 1

Daclatasvir (BMS 790052)

Type: Drug Disease: Hepatitis C Countries: Brazil and India Related documents: 21

Dapagliflozin-Empagliflozin-Insulin (Not Applicable)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 1

Darunavir (DRV)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 9

Darunavir+Ritonavir (DRV/r)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Dasatinib (DAS)

Type: Drug Disease: Chronic Myeloid Leukaemia Countries: India Related documents: 6

Delamanid (Delamanid)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 4

Descarboethoxyloratadine (DCL)

Type: Drug Disease: Allergy Countries: Argentina Related documents: 2

Desmopressin (DDAVP)

Type: Drug Disease: Diabetes insipidus Countries: Argentina Related documents: 1

Didanosine (ddl)

Type: Drug Disease: HIV/AIDS Countries: Thailand Related documents: 1

Dolutegravir (DTG)

Type: Drug Disease: Countries: Brazil and India Related documents: 9

Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC)

Type: Drug Disease: HIV Countries: Europe (EPO) and Thailand Related documents: 5

Eculizumab (ECU)

Type: Drug Disease: Paroxysmal nocturnal hemoglobinuria (PNH Countries: Brazil Related documents: 2

Efavirenz (EFV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 3

Eltrombopag (etlrombopag)

Type: Drug Disease: Thrombocytopenia and aplastic anemia Countries: Argentina Related documents: 1

Elvitegravir (EVG)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 2

Emtricitabine (FTC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Enfuvirtide (enfuvirtide)

Type: Drug Disease: HIV/AIDS Related documents: 0

Enzalutamide (ezm)

Type: Drug Disease: Prostate cancer Countries: India Related documents: 10

Estetrol (E4)

Type: Drug Disease: vasomotor menopausal symptoms Countries: Argentina Related documents: 2

Estetrol / Drospirenone (E4/DRSP)

Type: Drug Disease: Hormonal Contraceptive Countries: Argentina Related documents: 1

Estradiol (E2)

Type: Drug Disease: hormonal issues Countries: Argentina Related documents: 1

Estradiol and progesterone (Estradiol and progesterone)

Type: Drug Disease: Menopause Countries: Argentina Related documents: 1

Etanercept/Infliximab/Adalimumab (ETN/IFX/ADA)

Type: Drug Disease: Rheumatoid arthritis Countries: Argentina Related documents: 1

Etravirine (ETV)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 1

Farnesoid X receptor and Peroxisome proliferator-activated receptor agonist (FXR and PPAR Agonists)

Type: Drug Disease: Dyslipidemia Countries: Argentina Related documents: 1

Favipiravir (T-705)

Type: Drug Disease: Viral infection - Influenza Countries: Thailand Related documents: 1

Fenebrutinib (Not Applicable)

Type: Drug Disease: Bruton's tyrosine kinase (BTK Countries: Argentina Related documents: 1

Fexofenadine + cyclodextrins (FEX + CYD)

Type: Drug Disease: Rhinitis Countries: Argentina Related documents: 1

Firsocostat (GS-0976 (Not Applicable)

Type: Drug Disease: Obesity Countries: Argentina Related documents: 1

Fosamprenavir (FPV, f-APV)

Type: Drug Disease: HIV/AIDS Related documents: 0

GSK3036656 (GSK656)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 3

GSK656 (GSK656)

Type: Drug Disease: HCV Related documents: 0

Gamma-aminobutyric acid (GABA)

Type: Drug Disease: Cerebral disease Countries: Argentina Related documents: 1

Glatiramer acetate (GLA)

Type: Drug Disease: Multiple sclerosis Countries: India Related documents: 2

Glecaprevir (GLE)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 3

Hidrosmin (Not Applicable)

Type: Drug Disease: Chronic Venous Insufficiency Countries: Argentina Related documents: 1

Ibrutinib (IBR)

Type: Drug Disease: lymphoma Countries: Argentina Related documents: 1

Imatinib (ITB)

Type: Drug Disease: Cancer Countries: India Related documents: 6

Indinavir (IDV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Interferon (IFN)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 1

Islatravir (MK-8591)

Type: Drug Disease: HIV Countries: Ukraine Related documents: 1

Isoniazid-Rifapentine (3HP (Isoniazid-Rifapentine )

Type: Drug Disease: Latent Tuberculosis Infection Countries: Europe (EPO), India, and Thailand Related documents: 9

LAS191954 (Not Applicable)

Type: Drug Disease: APDS Countries: Argentina Related documents: 1

LIXISENATIDE (LIXISENATIDE (GLP-1))

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 1

Lamivudine (3TC)

Type: Drug Disease: HIV/AIDS Countries: Spain Related documents: 1

Lamivudine/Stavudine (3TC/d4T)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lamivudine/Stavudine + efavirenz (3TC/d4T + EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lamivudine/Stavudine/Nevirapine (3TC/d4T/NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Lapatinib ditosylate (GW572016)

Type: Drug Disease: Cancer Countries: India Related documents: 1

Ledipasvir (LDV)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Ledipasvir+Ribavirin+Other Anti-HCV Compounds (GS5885+RBV+other Anti-HCV Compounds)

Type: Drug Disease: Hepatitis C Related documents: 1

Lenacapavir (GS-6207)

Type: Drug Disease: HIV Countries: Argentina, India, and Viet Nam Related documents: 8

Levodopa and Carbidopa (L-Dopa and carbidopa)

Type: Drug Disease: Parkinson Disease Countries: Argentina Related documents: 1

Linaclotide (Not Applicable)

Type: Drug Disease: Irritable Bowl Syndrome Countries: Argentina Related documents: 1

Linezolid (Lzd)

Type: Drug Disease: Tuberculosis Countries: India and South Africa Related documents: 4

Lopinavir (LPV)

Type: Drug Disease: HIV/AIDS Countries: Argentina, India, and Kazakhstan Related documents: 12

Lopinavir/Ritonavir (LPV/r)

Type: Drug Disease: HIV/AIDS Countries: Belarus, Brazil, India, Ukraine, and Viet Nam Related documents: 31

MICONAZOLE (Miconazole)

Type: Drug Disease: Fungal Infections (Mycoses Countries: Argentina Related documents: 1

Maraviroc (MVC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Mesalazine (Not Applicable)

Type: Drug Disease: ulcerative colitis and Crohn's disease Countries: Argentina Related documents: 1

Molnupiravir (MK-4482 (MK-4482)

Type: Drug Disease: Influenza, Covid 19 Countries: Argentina, Brazil, India, and Russian Federation Related documents: 7

Nadifloxacin (NDFX)

Type: Drug Disease: Dermatological disease Countries: Argentina Related documents: 1

Nelfinavir (NFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Neurokinin antagonist/H1 antagonist/H2 antagonists (NK1/ H1A/ H2A)

Type: Drug Disease: Asthma Countries: Argentina Related documents: 1

Nevirapine (NVP)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 7

Nicotinamide (Vitamin B3)

Type: Drug Disease: dietary supplement Countries: Argentina Related documents: 1

Nilotinib (NILO)

Type: Drug Disease: Chronic Myeloid Leukaemia Countries: India Related documents: 3

Nusinersen ((Spinraza))

Type: Drug Disease: spinal muscular atrophy (SMA Countries: Colombia Related documents: 1

OPC-167832 (3,4-dihydrocarbostyril derivative (OPC-167832)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 2

Omega-3 polyunsaturated fatty acids (PUFAs)

Type: Drug Disease: Cancer cachexia Countries: Argentina Related documents: 1

Oprozomib (OPZ)

Type: Drug Disease: cancer Countries: Argentina Related documents: 1

Osimertinib (OSI)

Type: Drug Disease: non small-cell lung cancer (NSCLC Countries: Argentina Related documents: 1

Paclitaxel (PTX)

Type: Drug Disease: Cancer Countries: India Related documents: 3

Phosphoinositide 3-kinases and Coticosteroid (PI3Ks)

Type: Drug Disease: Cancer Countries: Argentina Related documents: 1

Pibrentasvir (PIB)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 3

Pirfenidone (PFD)

Type: Drug Disease: Chronic Diabetic Foot Ulcer Countries: Argentina Related documents: 1

Progesterone (P4)

Type: Drug Disease: Menopause Countries: Argentina Related documents: 3

Quinolone (QN)

Type: Drug Disease: Eye disease Countries: Argentina Related documents: 1

Quinolone/Nonsteroidal anti-inflammatory drugs (QN/NSAID)

Type: Drug Disease: Eye disease Countries: Argentina Related documents: 1

Raltegravir (RAL)

Type: Drug Disease: HIV/AIDS Countries: Argentina, India, and Thailand Related documents: 8

Remdesivir (GS-5734 (RDV)

Type: Drug Disease: Covid-19 Countries: Argentina and India Related documents: 7

Resveratrol + L-carnitine (RSV)

Type: Drug Disease: Cerebral disease Countries: Argentina Related documents: 1

Rilpivirine (TMC 278)

Type: Drug Disease: HIV/AIDS Related documents: 0

Ritonavir (r, RTV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 16

Rosuvastatin (ZD-4522)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 11

Sacubitril / Valsartan (ARNI)

Type: Drug Disease: Cardiovascular Diseases Countries: India Related documents: 11

Salmeterol [Long-acting β2 agonist (LABA (SLM)

Type: Drug Disease: Asthma Countries: Argentina Related documents: 1

Saquinavir (SQV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Semaglutide (Not Applicable)

Type: Drug Disease: Diabetes and Weight Management Countries: Argentina Related documents: 2

Simepravir (TMC 435)

Type: Drug Disease: Hepatitis C Countries: India Related documents: 2

Simeprevir (TMC 435)

Type: Drug Disease: Hepatitis C Related documents: 0

Sofosbuvir (GS7977)

Type: Drug Disease: Hepatitis C Countries: Argentina, Brazil, China, Europe (EPO), India, Korea (Republic of), Russian Federation, Ukraine, United States of America, and Viet Nam Related documents: 59

Sofosbuvir + Ledipasvir (GS7977+GS5885)

Type: Drug Disease: Hepatitis C Countries: Brazil, Colombia, India, and Ukraine Related documents: 4

Sofosbuvir+Ribavirin (GS7977+RBV)

Type: Drug Disease: Hepatitis C Countries: United States of America Related documents: 1

Sofosbuvir/Velpatasvir (SOF/VEL)

Type: Drug Disease: Hepatitis C Countries: China and India Related documents: 4

Sorafenib (SOR)

Type: Drug Disease: Hepatocellular Carcinoma (liver cancer Countries: India Related documents: 7

Stavudine (d4T)

Type: Drug Disease: HIV/AIDS Related documents: 0

Sunitinib (SU)

Type: Drug Disease: Cancer Countries: India Related documents: 4

Sutezolid (PNU-100480)

Type: Drug Disease: Tuberculosis Countries: Brazil and United States of America Related documents: 4

Telacebec (Q203 (Q203)

Type: Drug Disease: Tuberculosis Countries: India Related documents: 2

Teneligliptin (CS-0882)

Type: Drug Disease: Diabetes Countries: India Related documents: 2

Tenofovir Alafenamide Fumarate (TAF)

Type: Drug Disease: HIV Countries: Brazil, India, Thailand, and Ukraine Related documents: 11

Tenofovir disoproxil fumarate (TDF)

Type: Drug Disease: HIV/AIDS Countries: Brazil and India Related documents: 24

Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC)

Type: Drug Disease: HIV/AIDS Countries: Argentina, Brazil, India, and Thailand Related documents: 14

Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz (TDF/FTC/EFV)

Type: Drug Disease: HIV/AIDS Countries: Argentina and India Related documents: 7

Tenofovir disoproxil fumarate/Lamivudine (TDF/3TC)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tenofovir disoproxil fumarate/Lamivudine + nevirapine (TDF/3TC + NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tenofovir disoproxil fumarate/Lamivudine/Efavirenz (TDF/3TC/EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tipranavir (TPV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Tisagenlecleucel (Adoptive immunotherapy agent CTL019)

Type: Drug Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO) Related documents: 5

Toll-like Receptor 7 Agonists (TLR7)

Type: Drug Disease: Hepatitis B and C Countries: Argentina Related documents: 1

Trelagliptin (TLN)

Type: Drug Disease: Diabetes Countries: Argentina Related documents: 1

Tromethamine / Tramadol (Not Applicable)

Type: Drug Disease: Chronic and Acute Pain Countries: Argentina Related documents: 1

Valbenazine (NBI-98854)

Type: Drug Disease: tardive dyskinesia Countries: Argentina Related documents: 1

Valganciclovir (VAL)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 11

Velpatasvir (GS5816)

Type: Drug Disease: Hepatitis C Countries: Brazil, China, and India Related documents: 7

Vinorelbine (VRB)

Type: Drug Disease: Cancer Countries: Argentina Related documents: 1

Zidovudine (AZT, ZDV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Zidovudine/Lamivudine (AZT/3TC)

Type: Drug Disease: HIV/AIDS Countries: India Related documents: 3

Zidovudine/Lamivudine + efavirenz (AZT/3TC + EFV)

Type: Drug Disease: HIV/AIDS Related documents: 0

Zidovudine/Lamivudine/Abacavir (AZT/3TC/ABC)

Type: Drug Disease: HIV/AIDS Countries: United States of America Related documents: 1

Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP)

Type: Drug Disease: HIV/AIDS Related documents: 0

Linezolid (Lzd) application, (WO/2001/057035)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: South Africa

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/151760)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine decision, (8081/DELNP/2007)

Type: Patent office decision Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

lapatinib ditosylate (GW572016) application, (WO/2002/02552)

Type: Patent application Drugs: Lapatinib ditosylate Disease: Cancer Countries: India

100 Percent Life opposition, bedaquiline, (PCT/EP2016/051545)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Ukraine

5569760 prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

ABIA opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

ABIA opposition, TAF, (PI0112646-6)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

ABIA/GTPI opposition, Bedaquiline, (PI07196938)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

ABIA/GTPI opposition, Molnupiravir (MK-4482), (BR122021012627-5)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Covid-19 Countries: Brazil

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Bedaquiline, (TH0501002434)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Bedaquiline, (TH0701006189)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Dolutegravir/Abacavir/Lamivudine , (TH1201003753)

Type: Patent opposition Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Thailand

AIDS Access Foundation opposition, Bedaquiline, (TH0501005795)

Type: Patent opposition Drugs: Bedaquiline Disease: Latent Tuberculosis Infection Countries: Thailand

AIDS Access Foundation opposition, Bedaquiline, (TH170100416)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: Thailand

AIDS Access Foundation opposition, Favipiravir , (TH1101001988)

Type: Patent opposition Drugs: Favipiravir Disease: COVID 19 Countries: Thailand

AIDS Access Foundation opposition, Isoniazid-Rifapentine (3HP), (PCT/EP2014/065762)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Tuberculosis Countries: Thailand

AIDS Access Foundation opposition, Tenofovir Alafenamide Fumarate , (1401000784, PCT/US2012/050920)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV Countries: Thailand

Abacavir/Lamivudine decision, (EP1113803)

Type: Patent office decision Drugs: Abacavir/Lamivudine Disease: Hepatitis B Countries: Europe (EPO)

All-Ukrainian Network of People Living with HIV/AIDS opposition, Islatravir, (WO2017/139519 A1)

Type: Patent opposition Drugs: Islatravir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Lopinavir/Ritonavir, (WO 01/34119)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Lopinavir/Ritonavir, (WO 2005/039551)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir + Ledipasvir, (РСТ/US2012/055621 (a 2014 03617))

Type: Patent opposition Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir, (РСТ/US2011/030725 (а 2012 12444))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Sofosbuvir, (РСТ/US2011/044581(а 2013 01999))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Ukraine

All-Ukrainian Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate, (75889 (PCT/US01/23104))

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Ukraine

Amrita Majumdar opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Apotex Corp opposition, Zidovudine/Lamivudine/Abacavir, (US6417191)

Type: Patent opposition Drugs: Zidovudine/Lamivudine/Abacavir Disease: HIV/AIDS Countries: United States of America

Atazanavir application, (WO2005108349)

Type: Patent application Drugs: Atazanavir Disease: HIV Countries: Brazil

Atorvastatin decision, (DOP2002000413 in the Dominican Republic; the priority number is US 60/302,049.)

Type: Patent office decision Drugs: Atorvastatin Disease: Cholesterol reduction, cardiovascular diseases Countries: Dominican Republic

Atorvastatin, Amlodipine decision, (DOP2002000445 in the Dominican Republic; the priority number is US 60/309,133.)

Type: Patent office decision Drugs: Atorvastatin Disease: Cholesterol reduction, cardiovascular diseases, chest pain Countries: Dominican Republic

BDR Pharmaceuticals Ltd. opposition, Dasatinib , (4309/DELNP/2006)

Type: Patent opposition Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

BDR Pharmaceuticals Ltd. opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

BDR Pharmaceuticals Ltd. opposition, SOFOSBUVIR, (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

BPaL application, (WO2017/066053)

Type: Patent application Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Bedaquiline (BDQ) application, (WO/2005/117875)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2004/011436)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2004/011436)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2005/117875)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/067048)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/125769)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2006/131519)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2008/068231 )

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline application, (WO/2008/068231)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Bedaquiline application, (WO/2008/068231)

Type: Patent application Drugs: Bedaquiline Disease: Tuberculosis Countries: Europe (EPO)

Bedaquiline decision, (BR0312927)

Type: Patent office decision Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bedaquiline decision, (BR0506121)

Type: Patent office decision Drugs: Bedaquiline Disease: Tuberculosis Countries: Brazil

Bengal Network of People Living with HIV/AIDS (BNP+) and Firoz Khan opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2182/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2183/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)

Type: Patent opposition Drugs: Amlodipine/Losartan/Rosuvastatin Disease: Cholesterol reduction, cardiovascular diseases Countries: Argentina

CILFA opposition, BACE Inhibitor (LY2886721), (AR103406A1)

Type: Patent opposition Drugs: Beta Secretase Inhibitor Disease: alzheimer Countries: Argentina

CILFA opposition, Desmopressin, (AR107948A2)

Type: Patent opposition Drugs: Desmopressin Disease: nocturnal enuresis Countries: Argentina

CILFA opposition, ELVITEGRAVIR, (P050102058)

Type: Patent opposition Drugs: Elvitegravir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, FXR and PPAR AGONIST, (AR103624A1)

Type: Patent opposition Drugs: Farnesoid X receptor and Peroxisome proliferator-activated receptor agonist Disease: Dyslipidemia Countries: Argentina

CILFA opposition, Firsocostat - 2-(R)-2-(I-(2-(2-methoxyphenyl)-2- tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol2-yl)-2,4-dioxo-1,2-dihydrothieno[2, 3-d]pyrlmidin-3 (4H)- yl)-2-methylpropanoic acid, (AR107790A1)

Type: Patent opposition Drugs: Firsocostat (GS-0976 Disease: obesity Countries: Argentina

CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Type: Patent opposition Drugs: Gamma-aminobutyric acid Disease: Cerebral disease Countries: Argentina

CILFA opposition, LAS191954, (AR0100620A1)

Type: Patent opposition Drugs: LAS191954 Disease: APDS Countries: Argentina

CILFA opposition, LIXISENATIDE, (AR103415A1)

Type: Patent opposition Drugs: LIXISENATIDE Disease: DIABETES Countries: Argentina

CILFA opposition, LSD1 inhibitor, (AR107871A1)

Type: Patent opposition Drugs: Lysine Specific Demethylase Disease: Cancer Countries: Argentina

CILFA opposition, Levodopa - Carbidopa, (AR103448A1)

Type: Patent opposition Drugs: Levodopa and Carbidopa Disease: parkinson Countries: Argentina

CILFA opposition, MICONAZOLE, (AR103381A1)

Type: Patent opposition Drugs: MICONAZOLE Disease: MYCOSES Countries: Argentina

CILFA opposition, Nadifloxacin, (P990106490)

Type: Patent opposition Drugs: Nadifloxacin Disease: Dermatological disease Countries: Argentina

CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)

Type: Patent opposition Drugs: Phosphoinositide 3-kinases and Coticosteroid Disease: CANCER Countries: Argentina

CILFA opposition, Progesterone, (AR108072A1)

Type: Patent opposition Drugs: Progesterone Disease: menopause Countries: Argentina

CILFA opposition, Salmeterol, (AR100687A1)

Type: Patent opposition Drugs: Salmeterol [Long-acting β2 agonist (LABA Disease: Asthma Countries: Argentina

CILFA opposition, TLR7 agonists (JNJ-4964), (AR107548A1)

Type: Patent opposition Drugs: Toll-like Receptor 7 Agonists Disease: Hepatitis B and C Countries: Argentina

CILFA opposition, amino acids, (AR110548A1)

Type: Patent opposition Drugs: Amino acid dietary supplement Disease: cancer/dietary suplement Countries: Argentina

CILFA opposition, antibióticos de quinolona + compuestos NSAID, (P000103425)

Type: Patent opposition Drugs: Quinolone/Nonsteroidal anti-inflammatory drugs Disease: Eye disease Countries: Argentina

CILFA opposition, antibióticos de quinolona, (P000103426)

Type: Patent opposition Drugs: Quinolone Disease: Eye disease Countries: Argentina

CILFA opposition, bempedoic acid, (AR114396A1)

Type: Patent opposition Drugs: Bempedoic acid Disease: Cholesterol reduction, cardiovascular diseases Countries: Argentina

CILFA opposition, benzoilguanidinas (Markush), (P990106043)

Type: Patent opposition Drugs: Benzylguanidine Disease: Diabetes Countries: Argentina

CILFA opposition, botulinum toxin A, (AR112121A1)

Type: Patent opposition Drugs: Botulinum Toxin Disease: erectile dysfunction Countries: Argentina

CILFA opposition, brigatinib, (AR111169A1)

Type: Patent opposition Drugs: Brigatinib Disease: lung cancer Countries: Argentina

CILFA opposition, buprenorphine, (AR110468A1)

Type: Patent opposition Drugs: Buprenorphine Disease: dependence/addiction to opioids Countries: Argentina

CILFA opposition, cannabidiol, (AR115578A1)

Type: Patent opposition Drugs: Cannabidiol Disease: epilepsy Countries: Argentina

CILFA opposition, cannabinoid, (AR113749A1)

Type: Patent opposition Drugs: Cannabidiol Disease: Cancer Countries: Argentina

CILFA opposition, cariprazine, (AR112137A1)

Type: Patent opposition Drugs: Cariprazine Disease: schizophrenia/bipolar depression Countries: Argentina

CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Type: Patent opposition Drugs: Carvedilol+Hydrochlorothiazide Disease: Heart disease Countries: Argentina

CILFA opposition, celecoxib, (P990106069)

Type: Patent opposition Drugs: Celecoxib Disease: Osteoarthritis Countries: Argentina

CILFA opposition, cetirizine, (P990104039)

Type: Patent opposition Drugs: Cetirizine Disease: Asthma Countries: Argentina

CILFA opposition, clodronic acid, (AR110319A1)

Type: Patent opposition Drugs: Clodronic acid Disease: Osteoarthritis Countries: Argentina

CILFA opposition, cyclobenzaprine (C) , (P000104189)

Type: Patent opposition Drugs: Cyclobenzaprine Disease: Sleeping disorder Countries: Argentina

CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)

Type: Patent opposition Drugs: Dapagliflozin-Empagliflozin-Insulin Disease: diabetes Countries: Argentina

CILFA opposition, descarboetoxiloratadina + fosfatodibásico de calcio, (P000103668 divisional of P990103342)

Type: Patent opposition Drugs: Descarboethoxyloratadine Disease: Allergy Countries: Argentina

CILFA opposition, descarboetoxiloratadina, (P000103667 divisional of P990103342)

Type: Patent opposition Drugs: Descarboethoxyloratadine Disease: Allergy Countries: Argentina

CILFA opposition, efavirenz (EFV) , (P990101586)

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: Argentina

CILFA opposition, efavirenz (EFV) , (P990102809)

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: Argentina

CILFA opposition, eltrombopag, (AR107711A2)

Type: Patent opposition Drugs: Eltrombopag Disease: trombocitophenia Countries: Argentina

CILFA opposition, estetrol, (AR114798A1)

Type: Patent opposition Drugs: Estetrol Disease: hormonal alterations derived from menopause Countries: Argentina

CILFA opposition, estetrol, (AR114799A1)

Type: Patent opposition Drugs: Estetrol Disease: hormonal alterations derived from menopause Countries: Argentina

CILFA opposition, estetrol/drospirenone, (AR114357A1)

Type: Patent opposition Drugs: Estetrol / Drospirenone Disease: hormonal disease/contraceptive Countries: Argentina

CILFA opposition, estradiol, (AR107022A1)

Type: Patent opposition Drugs: Estradiol Disease: hormonal diseases Countries: Argentina

CILFA opposition, etanercept, Infliximab, Adalimumab, (P030103906)

Type: Patent opposition Drugs: Etanercept/Infliximab/Adalimumab Disease: Rheumatoid arthritis Countries: Argentina

CILFA opposition, fenibrutinib, (AR107751A1)

Type: Patent opposition Drugs: Fenebrutinib Disease: gastrointestinal diseases Countries: Argentina

CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Type: Patent opposition Drugs: Fexofenadine + cyclodextrins Disease: Rhinitis Countries: Argentina

CILFA opposition, hidrosmine, (AR113993A1)

Type: Patent opposition Drugs: Hidrosmin Disease: chronic venous insufficiency Countries: Argentina

CILFA opposition, ibrutinib, (AR107391)

Type: Patent opposition Drugs: Ibrutinib Disease: lymphoma Countries: Argentina

CILFA opposition, linaclotide, (AR118601A2)

Type: Patent opposition Drugs: Linaclotide Disease: irritable bowel syndrome Countries: Argentina

CILFA opposition, lopinavir (LPV) , (P060100645)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, mesalazine, (AR108231A1)

Type: Patent opposition Drugs: Mesalazine Disease: colonary diseases Countries: Argentina

CILFA opposition, neurokinin antagonist/H1 antagonist/H2 antagonists, (P990105080)

Type: Patent opposition Drugs: Neurokinin antagonist/H1 antagonist/H2 antagonists Disease: Asthma Countries: Argentina

CILFA opposition, nicotamide, (AR108233A1)

Type: Patent opposition Drugs: Nicotinamide Disease: dietary supplement Countries: Argentina

CILFA opposition, omega-3 polyunsaturated acids, (AR110450A1)

Type: Patent opposition Drugs: Omega-3 polyunsaturated fatty acids Disease: cachexia Countries: Argentina

CILFA opposition, oprozomib, (AR110374A1)

Type: Patent opposition Drugs: Oprozomib Disease: lynphoma/cancer Countries: Argentina

CILFA opposition, osimertinib, (AR115019A2)

Type: Patent opposition Drugs: Osimertinib Disease: Cancer Countries: Argentina

CILFA opposition, pirfenidone , (AR112474A1)

Type: Patent opposition Drugs: Pirfenidone Disease: chronic skin diseases from diabetes Countries: Argentina

CILFA opposition, progesterone - estradiol, (AR108073A1)

Type: Patent opposition Drugs: Estradiol and progesterone Disease: menopause Countries: Argentina

CILFA opposition, progesterone, (AR108074A1)

Type: Patent opposition Drugs: Progesterone Disease: menopause Countries: Argentina

CILFA opposition, progesterone, (AR108075A1)

Type: Patent opposition Drugs: Progesterone Disease: menopause Countries: Argentina

CILFA opposition, raltegravir (RAL) , (P050104911)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, reverastrol + L-carnitine, (P990105115)

Type: Patent opposition Drugs: Resveratrol + L-carnitine Disease: Cerebral disease Countries: Argentina

CILFA opposition, ritonavir (r, RTV) , (P070100928)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, ritonavir (r, RTV) , (P070100929)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: Argentina

CILFA opposition, rosuvastatin , (P000104058)

Type: Patent opposition Drugs: Rosuvastatin Disease: Cholesterol Countries: Argentina

CILFA opposition, rosuvastatin, (P000100408)

Type: Patent opposition Drugs: Rosuvastatin Disease: Diabetes Countries: Argentina

CILFA opposition, rosuvastatin, (P000104057)

Type: Patent opposition Drugs: Rosuvastatin Disease: Cholesterol Countries: Argentina

CILFA opposition, semaglutide, (AR112480A1)

Type: Patent opposition Drugs: Semaglutide Disease: diabetes/obesity Countries: Argentina

CILFA opposition, semaglutide, (AR114353A1)

Type: Patent opposition Drugs: Semaglutide Disease: diabetes Countries: Argentina

CILFA opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (P060102468)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: Argentina

CILFA opposition, trelagliptin, (AR109064A2)

Type: Patent opposition Drugs: Trelagliptin Disease: Diabetes Countries: Argentina

CILFA opposition, trometamine/tramadol, (AR114006A1)

Type: Patent opposition Drugs: Tromethamine / Tramadol Disease: chronic and acute pain Countries: Argentina

CILFA opposition, valbenazine, (AR112819A1)

Type: Patent opposition Drugs: Valbenazine Disease: tardive dyskinesia Countries: Argentina

CILFA opposition, vinorelbine, (AR107829A1)

Type: Patent opposition Drugs: Vinorelbine Disease: Cancer Countries: Argentina

Cabinet PLASSERAUD opposition, Tisagenlecleucel, (EP3214091)

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO)

Cabotegravir application, (WO/2010/011814)

Type: Patent application Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Cabotegravir application, (WO/2012/037320)

Type: Patent application Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Cancer Patient Aid Association (CPAA) opposition, Molnupiravir, (201717025098)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Influenza, Covid 19 Countries: India

Cancer Patient Aid Association (CPAA) opposition, imatinib (ITB) , (1602/MAS/98 )

Type: Patent opposition Drugs: Imatinib Disease: Cancer Countries: India

Charanjit Kumar Sehgal opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

Cipla Ltd. opposition, Darunavir and Ritonavir , (1647/DELNP/2004 (WO/2003/049746))

Type: Patent opposition Drugs: Darunavir+Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, Darunavir, (3598/DELNP/2004)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, Sorafenib, (IN/PCT/2001/799/MUM)

Type: Patent opposition Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Cipla Ltd. opposition, atazanavir (ATV) , (2933/DELNP/2009 (Divisional of 6425/DELNP/2006))

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (1647/DELNP/2004)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (2221/DELNP/2008)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, darunavir (DRV) , (5301/DELNP/2006 (Key Intermediates))

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, sunitinib (su) , (IN/PCT/2002/00785/DEL )

Type: Patent opposition Drugs: Sunitinib Disease: Cancer Countries: India

Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (9661/DELNP/2007)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: India

Cipla Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Colombia, Think-tank: "Medicines, Information and Power" at Universidad Nacional de Colombia. Centro de Pensamiento, Medicamentos, Información y Poder. (O.Lizarazo) opposition, crystalline Sofosbuvir, + amorphous ledipasvir, (WO2014120981 PCT/US2014/013953)

Type: Patent opposition Drugs: Sofosbuvir + Ledipasvir Disease: Hepatitis C Countries: Colombia

DNP+ and I-MAK opposition, Pibrentasvir, (1310/DELNP/2013)

Type: Patent opposition Drugs: Pibrentasvir Disease: Hepatitis C Countries: India

DNP+ opposition, Pibrentasvir, (201818021052 (Divisional of 1310/DELNP/2013))

Type: Patent opposition Drugs: Pibrentasvir Disease: HCV Countries: India

DPP-4 inhibitors decision, (DOP2009000215 in the Dominican Republic; the priority number is US 60/894,624.)

Type: Patent office decision Drugs: DPP-4 inhibitors Disease: Diabetes Countries: Dominican Republic

Daclatasvir application, (WO/2008/021927)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2009/020825)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2009/020828)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO/2011/059850 )

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir application, (WO2008021927)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

Daclatasvir (BMS 790052) application, (WO/2008/021928)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir (BMS 790052) application, (WO/2010/120621)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Daclatasvir (BMS790052) application, (WO/2009/102568)

Type: Patent application Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (806/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dalbir Singh opposition, Daclatasvir , (854/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Darunavir (DRV) application, (WO/2005/095410)

Type: Patent application Drugs: Darunavir Disease: HIV/AIDS Countries: India

Darunavir application, (WO/2003/106461)

Type: Patent application Drugs: Darunavir Disease: HIV/AIDS Countries: India

Dasatinib application, (WO/2000/062778)

Type: Patent application Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Dasatinib application, (WO/2005/077945)

Type: Patent application Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Dasatinib decision, (IN/PCT/2001/01138/MUM (IN203937))

Type: Patent office decision Drugs: Dasatinib Disease: Chronic Myeloid Leukaemia Countries: India

Delamanid application, ( WO/2007/043542)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2004/033463)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2004/033463)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delamanid application, (WO/2007/013477)

Type: Patent application Drugs: Delamanid Disease: Tuberculosis Countries: India

Delhi Network of Positive People (DNP+) and Ganesh Acharya opposition, Bedaquiline, (201727030045)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Delhi Network of Positive People (DNP+) opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)

Type: Patent opposition Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Delhi Network of Positive People (DNP+) opposition, Dolutegravir, (3865/KOLNP/2007)

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)

Type: Patent opposition Drugs: Glecaprevir Disease: Hepatitis C Countries: India

Delhi Network of Positive People (DNP+) opposition, Sofosbuvir/Velpatasvir, (201627008488)

Type: Patent opposition Drugs: Sofosbuvir/Velpatasvir Disease: Hepatitis C Countries: India

Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (201627039572)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Delhi Network of Positive People (DNP+) opposition, efavirenz (EFV) , (IN/PCT/2000/00553/MUM (granted as: 195367))

Type: Patent opposition Drugs: Efavirenz Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, raltegravir (RAL) , (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Delhi Network of Positive People (DNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Delhi Network of Positive People opposition, GSK3036656, (201717032083)

Type: Patent opposition Drugs: GSK3036656 Disease: Tuberculosis Countries: India

Delhi Network of Positive People opposition, Lenacapavir, (201917006277)

Type: Patent opposition Drugs: Lenacapavir Disease: HIV Countries: India

Dolutegravir application, (WO/2006/116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Dolutegravir application, (WO/2006/116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: India

Dolutegravir application, (WO2006116764)

Type: Patent application Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

Dolutegravir/Abacavir/Lamivudine decision, (EP2531027)

Type: Patent office decision Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Europe (EPO)

Dr. G.Subrahmanyam opposition, Daclatasvir, (854/DELNP/2010)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Dr. Reddy Laboratories Limited opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

EP0521471 prior art, (P000100408)

Type: Prior art Drugs: Rosuvastatin Disease: Diabetes

Eldred Tellis and Ganesh Acharya opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)

Type: Patent opposition Drugs: Bedaquiline, Pretomanid and Linezolid Disease: Tuberculosis Countries: India

Emory University opposition, lamivudine (3TC) , (EP90301335)

Type: Patent opposition Drugs: Lamivudine Disease: HIV/AIDS Countries: Spain

Entrepreneurship Development Center opposition, Molnupiravir, (201717025098)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Influenza, Covid 19 Countries: India

Enzalutamide application, (PCT/US2006/011417)

Type: Patent application Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide application, (WO/2006/124118)

Type: Patent application Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide court case, (9668/DELNP/2007)

Type: Court case Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide decision, (9668/DELNP/2007 (WO/2006/124118))

Type: Patent office decision Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Enzalutamide decision, (9668/DELNP/2007)

Type: Patent office decision Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

European Public Health Alliance (EPHA) opposition, Sofosbuvir, (EP2604620)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)

Farmanguinhos FIOCRUZ opposition, Eculizumab, (BR0708909-0/ US2007006606 / WO 2007/106585)

Type: Patent opposition Drugs: Eculizumab Disease: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH Countries: Brazil

Farmanguinhos Fiocruz opposition, Eculizumab, (BR12 2017 024057 9 / PCT US2007006606 / WO 2007/106585)

Type: Patent opposition Drugs: Eculizumab Disease: atypical hemolytic uremic syndrome (aHUS),paroxysmal nocturnal hemoglobinuria (PNH Countries: Brazil

Farmanguinhos opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

Farmanguinhos opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

Fresenius Kabi Oncology Limited opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate Cancer Countries: India

Fresenius Kabi Oncology Limited opposition, Sorafenib, (1960/DELNP/2007)

Type: Patent opposition Drugs: Sorafenib Disease: Hepatocellular Carcinoma (liver cancer Countries: India

Fresenius Kabi Oncology Ltd opposition, Nilotinib, (9322/DELNP/2007)

Type: Patent opposition Drugs: Nilotinib Disease: Chronic Myeloid Leukaemia Countries: India

Fundación GEP and Red Argentina de Personas Positivas opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (AR 054060 A1)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine/Efavirenz Disease: HIV/AIDS Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR109364A1)

Type: Patent opposition Drugs: Lenacapavir Disease: HIV Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Covid-19 Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))

Type: Patent opposition Drugs: Remdesivir (GS-5734 Disease: Covid-19 Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Sofosbuvir, (WO/2008/121634)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Argentina

Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Argentina

GB2262229 prior art, (P000104057, P000104058)

Type: Prior art Drugs: Rosuvastatin Disease:

GS-5885+Ribavirin+other Anti-HCV Ledipasvir+Ribavirin+other Anti-HCV Compounds (GS5885+RBV+other Anti-HCV Compounds) application, (WO2011156757)

Type: Patent application Drugs: Ledipasvir+Ribavirin+Other Anti-HCV Compounds Disease: Hepatitis C

GSK656 application, (WO/2012/033858)

Type: Patent application Drugs: GSK3036656 Disease: Tuberculosis Countries: India

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Atazanavir, (PI0509595-6)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Daclatasvir , (PI0716483-1 - WO2008021927)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Daclatasvir , (PI0716483-1)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Dolutegravir, (PI0610030-9 (US 2006/016604 - WO 2006/116764))

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9 - WO2005003147)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0410846-9)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0809654-6 - WO2008121634)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6 - WO200208241)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir disoproxil fumarate/Emtricitabine, (PI0406760-6 - WO2004064845)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Velpatasvir, (BR112013012091-6)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: Brazil

GTPI opposition, Dolutegravir, (PI0610030-9 (WO2006116764))

Type: Patent opposition Drugs: Dolutegravir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, Sofosbuvir, (PI0410846-9 e divisionais (PI0419342-­3, PI0419343-­1, PI0419344-­0, PI0419345-8) - WO2005003147)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Brazil

GTPI opposition, lopinavir/ritonavir (LPV/r) , (PI0413882­‐1)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9816239-0 (Divisional to PI9801145-4) )

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate/Emtricitabine Disease: HIV/AIDS Countries: Brazil

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)

Type: Patent opposition Drugs: Bedaquiline Disease: Tuberculosis Countries: India

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002757)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002758)

Type: Patent opposition Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Ganesh Acharya opposition, GSK3036656, (602/KOLNP/2013)

Type: Patent opposition Drugs: GSK3036656 Disease: Tuberculosis Countries: India

Ganesh Acharya opposition, OPC-167832, (201737004817)

Type: Patent opposition Drugs: OPC-167832 (3,4-dihydrocarbostyril derivative Disease: Tuberculosis Countries: India

Glecaprevir application, (WO/2012/040167)

Type: Patent application Drugs: Glecaprevir Disease: HCV Countries: India

Grupo Plebio. Oscar Lizarazo. UAEM-UNAL-Colombia; Centro de Pensamiento, Medicamentos Información y Poder (Universidad Nacional) opposition, Nusinersen (Spinraza), (WO/2018/014041 PCT/US2017/042463 NC2019/0001236)

Type: Patent opposition Drugs: Nusinersen Disease: Spinal muscular atrophy (SMA Countries: Colombia

Gujarat State Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)

Type: Patent opposition Drugs: Tenofovir Alafenamide Fumarate Disease: HIV/AIDS Countries: India

Hemavathi R opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

Henminlun opposition, Cabotegravir, (303371)

Type: Patent opposition Drugs: Cabotegravir Disease: HIV/AIDS Countries: India

Hepatitis Coalition, Nagaland (HepCon), Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai and Asia Pacific Network of Positive People (APN+), all of whom are represented by the Lawyers Collective opposition, daclatasvir, (853/DELNP/2009)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

ITPC-EECA opposition, Molnupiravir (MK-4482), (EA202091005)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Covid-19 Countries: Russian Federation

Imatinib court case, (1602/MAS/1998)

Type: Court case Drugs: Imatinib Disease: Chronic Myeloid Leukaemia Countries: India

India Cares Foundation opposition, Sofosbuvir, (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

India Cares opposition, Sofosbuvir, (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (2076/DEL/1997)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (896/DEL/2002 (divisional from 2174/DEL/1998))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (963/DEL/2002 (divisional to 2174/DEL/1998)

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Karnataka Network of Positive People (KNP+) opposition, atazanavir (ATV) , (805/MAS/1997 )

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Manipur Network of Positive People (MNP+) opposition, zidovudine/lamivudine (AZT/3TC) , (2044/CAL/1997)

Type: Patent opposition Drugs: Zidovudine/Lamivudine Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Positive Women Network (PWN+) opposition, nevirapine (NVP) , (2485/DEL/1998)

Type: Patent opposition Drugs: Nevirapine Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) and Tamil Nadu Networking People with HIV/AIDS (TNNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) opposition, Raltegravir, (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+) opposition, abacavir (ABC) , (872/CAL/98)

Type: Patent opposition Drugs: Abacavir Disease: HIV/AIDS Countries: India

Indian Network of People Living with HIV/AIDS (INP+), Delhi Network of Positive People (DNP+) and Network of Maharashtra People with HIV (NMP+) opposition, lopinavir (LPV) , (IN/PCT/2002/1243/MUM)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Darunavir and Etravirine, (35/MUMNP/2010)

Type: Patent opposition Drugs: Darunavir Disease: HIV/AIDS Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Type: Patent opposition Drugs: Enzalutamide Disease: Prostate cancer Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, Simepravir, (10158/DELNP/2007)

Type: Patent opposition Drugs: Simepravir Disease: Hepatitis C Countries: India

Indian Pharmaceutical Alliance (IPA) opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Indian Pharmaceutical Alliance opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

Indian Pharmaceutical Alliance opposition, daclatasvir, (3372/CHENP/2012)

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (3999/CHENP/2012 (PCT/US2010/055045))

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (806/DELNP/2010 (PCT/US2008/071734))

Type: Patent opposition Drugs: Daclatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Glecaprevir, (2891/DELNP/2013)

Type: Patent opposition Drugs: Glecaprevir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (9149/CHENP/2012)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir (GS7977) , (3658/KOLNP/2009)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,964,580)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,284,342)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,633,309)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,735,372)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,393,256)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: United States of America

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Initiative for Medicines, Access & Knowledge (I-Mak), Delhi Network of Positive People (DNP+) and Indian Network of People Living with HIV/AIDS (INP+) opposition, lopinavir/ritonavir (LPV/r) , (IN/PCT/2001/01312/MUM)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Initiative for Medicines, Access and Knowledge (I-MAK) opposition, Sofosbuvir, (CN 200480019148.4)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: China

Initiative for Medicines, Access and Knowledge (I-MAK) opposition, Sofosbuvir, (CN 200880018024.2 (WO/2008/121634))

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: China

Intermed Labs opposition, tenofovir disoproxil fumarate (TDF) , (602/DEL/2007 (Divisional from 2076/DEL/1997))

Type: Patent opposition Drugs: Tenofovir disoproxil fumarate Disease: HIV/AIDS Countries: India

International Preliminary Examination Report prior art, (PCT/US01/04813)

Type: Prior art Drugs: Sunitinib Disease: Cancer

Isoniazid-Rifapentine (3HP) application, (WO/2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: India

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO/2015/011162)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Isoniazid-Rifapentine (3HP) application, (WO2015/011161)

Type: Patent application Drugs: Isoniazid-Rifapentine (3HP Disease: Latent Tuberculosis Infection Countries: Europe (EPO)

Keelu Lakshminarayana opposition, Molnupiravir, (202017019418)

Type: Patent opposition Drugs: Molnupiravir (MK-4482 Disease: Influenza, Covid 19 Countries: India

Ketakee S Durve opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

Kumar Sushobhan opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Type: Patent opposition Drugs: Sacubitril / Valsartan Disease: Cardiovascular Disease Countries: India

LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)

Type: Patent opposition Drugs: Dolutegravir/Abacavir/Lamivudine Disease: HIV/AIDS Countries: Europe (EPO)

Ledipasvir application, (WO/2010/132601)

Type: Patent application Drugs: Ledipasvir Disease: Hepatitis C Countries: India

Lenacapavir application, (WO/2018/035359)

Type: Patent application Drugs: Lenacapavir Disease: HIV Countries: India

Linezolid (Lzd) application, (WO/2001/057035 )

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: India

Linezolid (Lzd) application, (WO/2001/057035)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: India

Linezolid application, (WO/1995/007271)

Type: Patent application Drugs: Linezolid Disease: Tuberculosis Countries: South Africa

Lopinavir (LPV) application, (WO/2001/74787 )

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Lopinavir (LPV) application, (WO/2002/018349)

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Lopinavir (LPV) application, (WO/2002/018349)

Type: Patent application Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Low-Voltage scanning Electron Microscope determination of nevirapine crystal habit in a pharmaceutical suspension prior art, (2485/DEL/1998)

Type: Prior art Drugs: Nevirapine Disease: HIV/AIDS

Lupin Ltd. opposition, Teneligliptin, (3176/KOLNP/2007)

Type: Patent opposition Drugs: Teneligliptin Disease: Diabetes Countries: India

MSN Laboratories Private Limited opposition, Ledipasvir, (9313/DELNP/2011)

Type: Patent opposition Drugs: Ledipasvir Disease: Hepatitis C Countries: India

Matrix Laboratories Ltd & Indian Network of People Living with HIV/AIDS (INP+) opposition, atazanavir (ATV) , (310/CHE/2007 (Divisional of 805/MAS/1997))

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, atazanavir (ATV) , (WO/2013/176772)

Type: Patent opposition Drugs: Atazanavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (259/MUMNP/2003)

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (894/MUMNP/2007 (Divisional of IN/PCT/2002/1243/MUM))

Type: Patent opposition Drugs: Lopinavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (1638/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (676/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (677/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Type: Patent opposition Drugs: Ritonavir Disease: HIV/AIDS Countries: India

Matrix Laboratories Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Type: Patent opposition Drugs: Valganciclovir Disease: HIV/AIDS Countries: India

Medicine Open Access Initiative (MOA-I) + SPM Corporation opposition, Sofosbuvir, (PCT/US2014/013953)

Type: Patent opposition Drugs: Sofosbuvir Disease: HCV Countries: Viet Nam

Merck, Novartis, Crucell Holand, Dr.Franz-Josef and Strawman opposition, Pneumococcal Conjugate Vaccine, (EP 1868645)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Miltenyi Biotec GmbH opposition, Tisagenlecleucel, (EP3214091)

Type: Patent opposition Drugs: Tisagenlecleucel Disease: Acute lymphoblastic leukemia and Diffuse large B cell lymphoma Countries: Europe (EPO)

Mr. Eldred Tellis opposition, Velpatasvir, (4351/DELNP/2013)

Type: Patent opposition Drugs: Velpatasvir Disease: Hepatitis C Countries: India

Mylan Laboratories India opposition, Raltegravir, (4187/DELNP/2007)

Type: Patent opposition Drugs: Raltegravir Disease: HIV Countries: India

Mylan Laboratories India opposition, glatiramer acetate injection , (2234/DELNP/2007 (eq. PCT/US2005/032395 and US60/608,843))

Type: Patent opposition Drugs: Glatiramer acetate Disease: multiple sclerosis (MS Countries: India

Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (1732/MUMNP/2009)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (6733/DELNP/2007)

Type: Patent opposition Drugs: Lopinavir/Ritonavir Disease: HIV/AIDS Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Médecins Sans Frontières (MSF) opposition, Sofosbuvir, (EP2604620)

Type: Patent opposition Drugs: Sofosbuvir Disease: Hepatitis C Countries: Europe (EPO)